FDA Inspection 1149832 — Cary (NMI) Fu M.D.

Cary (NMI) Fu M.D. — FEI 3019665056

The FDA completed an inspection of Cary (NMI) Fu M.D. on August 19, 2021 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 19, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical Investigator (CI)